Tag: CX 2026
Leading vascular access surgeons call for solutions to fibrin sheath formation...
Central venous catheters (CVCs) are a widely used form of dialysis access, yet for years the clinical community has avoided discussing how to improve...
Innovation is dead in vascular access? A CX 2026 debate with...
Innovation is dead in vascular access. That was the unenviable challenge Nicholas Inston (Birmingham, UK) took on at the 2026 Charing Cross (CX) Symposium...
IN.PACT AV access post-approval study: Outcomes from extended cohort “consistent with...
Extended cohort outcomes from the IN.PACT arteriovenous (AV) access postmarket study were “clinically reasonable and consistent with prior experience”, the 2026 Charing Cross (CX)...
One-year aXess data unlock “new category of vascular access”
“Twelve-month results of the aXess show that the graft is safe to implant, supports early and effective dialysis use, and is associated with...
Innovation meets evidence in CX 2026 vascular access session
What are the best approaches for managing arteriovenous fistula (AVF) stenosis? What role should surveillance play in vascular access management? Is innovation in the...